Trend

Last Previous Currency Date Chng
60.85 60.47 USD 26/04/01 +0.63

Terms

Isin LU0109394709
Contract Type Sicav
Currency USD
Class A
Risk Class 5
Assogestioni Category Azionari Salute
Declared Benchmark 100% Nasdaq Biotech
Start Date 00/04/03
Advisor Name Evan McCulloch; Vincent Xiang
Fund Asset Under Management N.Av.

Performance

Cumulatives
1 month +1.43
Ytd +4.17
1 year +51.88
3 years +74.32
5 years +43.91
Yearly
02/28/2025 +33.63
02/29/2024 +9.17
02/28/2023 +13.22
02/28/2022 -7.09
02/28/2021 -10.47
Rating
Score
90.6186

Company

Franklin Templeton Intern Serv
8A, rue Albert Borschette L-1246 - Lussemburgo
Tel. N.Av.

Costs

Entrance (ACP) Min: 1,5000 - Max: 5,7500
Management 1.5
Reimbursement 0%
Administrative 0%
Switch 0%
Tunnel 0

Subscription

One Solution
Initial 2500,0000 USD
Integrative 500,0000 USD
Accumulation Plan
Duration N.Av.
Minimum Payment Unit N.Av.
Initial Payment 2500,0000

Costs

Entrance (ACP) Min: 1,5000 - Max: 5,7500
Management 1.5
Reimbursement 0%
Administrative 0%
Switch 0%
Tunnel 0

Performance

Cumulatives
1 day +5.72
1 week +6.42
1 month +1.43
3 months +4.17
6 months +28.48
From the beginning of the year +4.17
1 year +51.88
2 years +32.81
3 years +74.32
4 years +72.22
5 years +43.91
Yearly
02/28/2025 +33.63
02/29/2024 +9.17
02/28/2023 +13.22
02/28/2022 -7.09
02/28/2021 -10.47


Rating
Rating Rating Rating Rating Rating
Score
90.6186

Efficiency Indicators

Sharpe 1 year 0.97
Benchmark 1 year N.Av.
Sharpe 3 years 0.68
Benchmark 3 years N.Av.
Sharpe 5 years 0.3016
Benchmark 5 years N.Av.
Sortino 1 year 2.0274
Benchmark 1 year N.Av.
Sortino 3 years 1.4553
Benchmark 3 years N.Av.
Sortino 5 years 0.5253
Benchmark 5 years N.Av.

Absolute

Standard Volatility
1 year +26.92
3 years +20.95
5 years +19.58
Negative Volatility
1 year +12.91
3 years +9.79
5 years +11.17

Benchmark

Standard Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Negative Volatility
1 year N.Av.
3 years N.Av.
5 years N.Av.
Updated Monthly - 26/02/27

Relative

Sharpe 0.68
Sortino 1.4553
Bull Market +10.75
Bear Market -4.07
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Benchmark N.Av.
Three years data
Risk Class 5

General

  1 year 18,005 3 years 15,888 5 years 14,134
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 18,005
988
  
+35.43
3 years 15,888
1,031
  
+68.85
5 years 14,134
5,109
  
+37.46
Performance
988 +35.43 1,031 +68.85 5,109 +37.46
Total Volatility
1 year 18,005
22,019
  
+26.92
3 years 15,888
18,979
  
+20.95
5 years 14,134
16,360
  
+19.58
Total Volatility
22,019 +26.92 18,979 +20.95 16,360 +19.58
Negative Volatility
1 year 18,005
20,740
  
+12.91
3 years 15,888
17,686
  
+9.79
5 years 14,134
15,326
  
+11.17
Negative Volatility
20,740 +12.91 17,686 +9.79 15,326 +11.17
Sharpe Index
1 year 18,005
6,911
  
+0.97
3 years 15,888
6,293
  
+0.68
5 years 14,134
7,297
  
+0.30
Sharpe Index
6,911 +0.97 6,293 +0.68 7,297 +0.30
Sortino Index
1 year 18,005
5,565
  
+2.03
3 years 15,888
4,470
  
+1.46
5 years 14,134
6,543
  
+0.53
Sortino Index
5,565 +2.03 4,470 +1.46 7,297 +0.53

By Category

  1 year 18,005 3 years 15,888 5 years 14,134
  Pos. Chng % Pos. Chng % Pos. Chng %
Performance
1 year 18,005
8
  
+35.43
3 years 15,888
5
  
+68.85
5 years 14,134
16
  
+37.46
Performance
8 +35.43 5 +68.85 16 +37.46
Total Volatility
1 year 18,005
116
  
+26.92
3 years 15,888
99
  
+20.95
5 years 14,134
77
  
+19.58
Total Volatility
116 +26.92 99 +20.95 77 +19.58
Negative Volatility
1 year 18,005
75
  
+12.91
3 years 15,888
52
  
+9.79
5 years 14,134
65
  
+11.17
Negative Volatility
75 +12.91 52 +9.79 65 +11.17
Sharpe Index
1 year 18,005
7
  
+0.97
3 years 15,888
5
  
+0.68
5 years 14,134
23
  
+0.30
Sharpe Index
7 +0.97 5 +0.68 23 +0.30
Sortino Index
1 year 18,005
7
  
+2.03
3 years 15,888
3
  
+1.46
5 years 14,134
17
  
+0.53
Sortino Index
7 +2.03 3 +1.46 17 +0.53

Foreign Funds - Franklin Biotechnology Discovery A $: Performance, Terms, Fees, Risk, Rating


The Exchange accepts no responsability for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.


You will be redirected in five seconds.